Home ›
Entities
› academia
› Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Research article (American Journal of Psychiatry, 2021) · cited 80× · AI/ML
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Summary
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial is a scholarly article[1].
Key Facts
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial. Retrieved May 24, 2026, from https://4ort.xyz/entity/impact-of-the-kcnq2-3-channel-opener-ezogabine-on-reward-circuit-activity-and-clinical-symptoms-in-depression-results-fr
MLA“Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/impact-of-the-kcnq2-3-channel-opener-ezogabine-on-reward-circuit-activity-and-clinical-symptoms-in-depression-results-fr.
BibTeX@misc{4ortxyz_impact-of-the-kcnq2-3-channel-opener-ezogabine-on-reward-circuit-activity-and-clinical-symptoms-in-depression-results-fr_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial}}, year = {2026}, url = {https://4ort.xyz/entity/impact-of-the-kcnq2-3-channel-opener-ezogabine-on-reward-circuit-activity-and-clinical-symptoms-in-depression-results-fr}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial — https://4ort.xyz/entity/impact-of-the-kcnq2-3-channel-opener-ezogabine-on-reward-circuit-activity-and-clinical-symptoms-in-depression-results-fr (retrieved 2026-05-24)
